X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Unichem Lab with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 UNICHEM LAB   ADCOCK INGRAM
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
ADCOCK INGRAM
Jun-14
UNICHEM LAB/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs334381-   
Low Rs174275-   
Sales per share (Unadj.) Rs146.9113.4-  
Earnings per share (Unadj.) Rs11.9-28.6-  
Cash flow per share (Unadj.) Rs16.2-23.7-  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs105.189.0-  
Shares outstanding (eoy) m90.84168.78-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.72.9 59.8%   
Avg P/E ratio x21.4-11.5 -186.0%  
P/CF ratio (eoy) x15.7-13.9 -113.3%  
Price / Book Value ratio x2.43.7 65.6%  
Dividend payout %16.80-   
Avg Mkt Cap Rs m23,07355,398 41.7%   
No. of employees `0005.74.3 132.1%   
Total wages/salary Rs m2,5583,477 73.6%   
Avg. sales/employee Rs Th2,352.54,459.9 52.7%   
Avg. wages/employee Rs Th450.9809.9 55.7%   
Avg. net profit/employee Rs Th190.4-1,123.8 -16.9%   
INCOME DATA
Net Sales Rs m13,34619,146 69.7%  
Other income Rs m192134 143.1%   
Total revenues Rs m13,53819,280 70.2%   
Gross profit Rs m1,639-3,318 -49.4%  
Depreciation Rs m390826 47.2%   
Interest Rs m29519 5.6%   
Profit before tax Rs m1,412-4,529 -31.2%   
Minority Interest Rs m0-13 0.0%   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m293283 103.4%   
Profit after tax Rs m1,080-4,824 -22.4%  
Gross profit margin %12.3-17.3 -70.9%  
Effective tax rate %20.7-6.2 -331.7%   
Net profit margin %8.1-25.2 -32.1%  
BALANCE SHEET DATA
Current assets Rs m5,97914,023 42.6%   
Current liabilities Rs m2,4327,890 30.8%   
Net working cap to sales %26.632.0 83.0%  
Current ratio x2.51.8 138.3%  
Inventory Days Days63111 56.9%  
Debtors Days Days60124 48.7%  
Net fixed assets Rs m6,4038,174 78.3%   
Share capital Rs m18289 204.4%   
"Free" reserves Rs m9,2930-   
Net worth Rs m9,54815,028 63.5%   
Long term debt Rs m2305,281 4.4%   
Total assets Rs m12,84328,389 45.2%  
Interest coverage x50.0-7.7 -647.0%   
Debt to equity ratio x00.4 6.9%  
Sales to assets ratio x1.00.7 154.1%   
Return on assets %8.6-15.2 -56.9%  
Return on equity %11.3-32.1 -35.2%  
Return on capital %14.3-19.8 -72.4%  
Exports to sales %29.20-   
Imports to sales %6.30-   
Net fx Rs m3,1940-   
CASH FLOW
From Operations Rs m1,1191,634 68.5%  
From Investments Rs m-853-502 170.0%  
From Financial Activity Rs m-3344,793 -7.0%  
Net Cashflow Rs m-685,925 -1.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.26 Rs / ZAR

Compare UNICHEM LAB With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare UNICHEM LAB With: PFIZER  JUBILANT LIFE SCIENCES  MERCK LTD  NATCO PHARMA  STERLING BIOTECH  



Today's Market

Sensex Trades on a Volatile Note; Airtel, Idea Down by 5%(01:30 pm)

After opening the day in green share markets in India witnessed choppy trading activity and are presently trading above the dotted line.

Related Views On News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

'Smart Money' Enters Bitcoin. Will You?(Smart Contrarian)

Jan 17, 2018

As institutional money enters bitcoin, the gains over the last year could just be the tip of the iceberg.

Increasing Divergence Between Bond Yields and Earnings Yield(Chart Of The Day)

Jan 11, 2018

Over the past couple of months, bond yields have risen, but earning yields have fallen, increasing divergence.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jan 24, 2018 03:05 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS